Alk-Abello A/S header image

Alk-Abello A/S

ALK B

Equity

ISIN DK0061802139 / Valor 117689788

Nasdaq Copenhagen Equities (2026-05-06)
DKK 257.80+0.55%

Alk-Abello A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alk-Abello A/S is a Danish pharmaceutical company specializing in the development and production of allergy immunotherapy products. The company is committed to advancing long-term allergy treatment and aims to establish a leading position in the management of food allergies and anaphylaxis. Alk-Abello's strategic focus includes expanding its portfolio of respiratory allergy tablets and enhancing its pediatric coverage. The company is also exploring partnerships to accelerate the commercial adoption of its products across various markets. By prioritizing innovation and optimizing its operations, Alk-Abello seeks to address unmet needs in adjacent allergic conditions. The company emphasizes cultivating its organizational capabilities to foster a high-performance culture and improve access to allergy care.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

54.8%1Y
211%3Y
94.1%5Y

Performance

26.2%1Y
33.8%3Y
37.1%5Y

Volatility

Market cap

8174 M

Market cap (USD)

Daily traded volume (Shares)

313,358

Daily traded volume (Shares)

1 day high/low

161.3 / 157.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 43.76
Udemy Inc
Udemy Inc Udemy Inc Valor: 114176816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%USD 4.80
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 61.43
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.18%USD 23.90
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.00%USD 68.09
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.11%USD 232.55
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.02%USD 14.62
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%USD 70.99
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%CHF 22.70
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.58%GBP 11.18